EHA & ERN Spotlight on Hypereosinophilic Syndrome

Date:
- April 15, 2024
- May 13, 2024
- May 20, 2024
- June 3; 2024

Location: Online (Zoom)
Format: Webinar (4)

The role of BMT in the treatment of malignant hemopathy in 2024

Date: April 19, 2024
Location: Tirana, Albania
Format: Hybrid

Date: May 14, 2024, 18:00-19:00 (CEST)
Format: Virtual

EHA2024 Hybrid Congress

Date: June 13-16, 2024
Location: Madrid, Spain
Format: Hybrid

T Cell Lymphomas

Date: June 29-30, 2024
Location: Ankara, Türkiye
Format: In-person

Recent advances in lymphoid and myeloid malignancies

Date: September 13-14, 2024
Location: Almaty, Kazakhstan
Format: In-person

Bridging between functional and genomic precision medicine

Date: September 25-27, 2024
Location: Copenhagen, Denmark
Format: In-person

Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT)

Date: October 2-5, 2024
Location: London, United Kingdom

New aspects in diagnostic choices and treatment options of hematological malignancies

Date: October 18-20, 2024
Location: Tbilisi, Georgia
Format: In-person

Myeloproliferative disorders

Date: November 14-15, 2024
Location: Varna, Bulgaria
Format: Hybrid

Bone marrow failure and leukemia predisposition syndromes

Date: November 15-17, 2024
Location: Paris, France
Format: In-person

7th European CAR T-cell Meeting

Dates: February 6-8, 2025
Location: Strasbourg, France
Format: Hybrid

EHA Research Conference 2025

"Transcriptional control and chromatin alterations in normal and abnormal hematopoiesis"

Date: March 17-20, 2025
Location: Málaga, Spain
Format: In-person